Breast carcinoma survival in Europe and the United States (Q47211607)

11 January 2018

title

Breast carcinoma survival in Europe and the United States (English)

1 reference

11 January 2018

1 reference

1

1 reference

11 January 2018

Henrik Møller

18

1 reference

11 January 2018

Pascale Grosclaude

object named as

Pascale Grosclaude

14

0 references

Michel P. Coleman

object named as

Michel P Coleman

4

0 references

author name string

Claudia Allemani

2

1 reference

11 January 2018

Franco Berrino

3

1 reference

11 January 2018

Tiiu Aareleid

5

1 reference

11 January 2018

Gilles Chaplain

6

1 reference

11 January 2018

Jan Willem Coebergh

7

1 reference

11 January 2018

Marc Colonna

8

1 reference

11 January 2018

Paolo Crosignani

9

1 reference

11 January 2018

Arlette Danzon

10

1 reference

11 January 2018

Massimo Federico

11

1 reference

11 January 2018

Massimo Federico

12

1 reference

11 January 2018

Lorenzo Gafà

13

1 reference

11 January 2018

Guy Hédelin

15

1 reference

11 January 2018

Josette Macè-Lesech

16

1 reference

11 January 2018

Carmen Martinez Garcia

17

1 reference

11 January 2018

Eugenio Paci

19

1 reference

11 January 2018

Nicole Raverdy

20

1 reference

11 January 2018

Brigitte Tretarre

21

1 reference

11 January 2018

Evelyn M I Williams

22

1 reference

11 January 2018

European Concerted Action on Survival and Care of Cancer Patients (EUROCARE) Working Group

23

1 reference

11 January 2018

language of work or name

English

0 references

publication date

1 February 2004

1 reference

11 January 2018

published in

Cancer

1 reference

11 January 2018

volume

100

1 reference

11 January 2018

page(s)

715-722

1 reference

11 January 2018

issue

4

1 reference

11 January 2018

Survival of women with breast cancer in Europe: variation with age, year of diagnosis and country. The EUROCARE Working Group.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20038

Variations in survival from breast cancer in Europe by age and country, 1978-1989. EUROCARE Working Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20038

A computer program package for relative survival analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20038

Regression models for relative survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20038

Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20038

Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20038

Breast cancer incidence and mortality trends in 16 European countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20038

Socioeconomic inequalities in cancer survival in England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20038

Projecting SEER cancer survival rates to the US: an ecological regression approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20038

Differences in breast cancer stage, treatment, and survival by race and ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20038

Breast cancer survival and treatment in health maintenance organization and fee-for-service settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20038

Treatment differences and other prognostic factors related to breast cancer survival. Delivery systems and medical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20038

Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20038

Differences in stage and therapy for breast cancer across Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20038

7 January 2021

The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20038

7 January 2021

Relative survival and the estimation of net survival: elements for further discussion.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20038

7 January 2021

Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20038

7 January 2021

The EUROCARE study of survival of cancer patients in Europe

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20038

7 January 2021

Recent trends in breast cancer mortality among white and black US women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20038

7 January 2021

Race, socioeconomic status, and breast cancer treatment and survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20038

7 January 2021

Identifiers

DOI

10.1002/CNCR.20038

1 reference

11 January 2018

PubMed ID

14770426

1 reference

11 January 2018